A new Korean Research Investment for Global Health Technology (RIGHT) Fund to advance innovative neglected-disease technologies.
Peter Jay HotezKim BushAndrin OswaldGlenn RockmanIn-Taek LimYoungmee JeeChang Jin MoonJerome H KimYounbeen KimPublished in: PLoS neglected tropical diseases (2020)
In 2018, the government of the Republic of Korea (ROK), South Korean life science companies, and a group of international funders led by the Bill & Melinda Gates Foundation launched a new and innovative funding agency to support neglected-disease research and development (R&D). The new venture is known as the Research Investment for Global Health Technology (RIGHT) Fund.